Jens Renstrup
Chief Tech/Sci/R&D Officer bei BIOHAVEN LTD.
Profil
Jens Renstrup's current job is Senior Director-Medical Affairs at Biohaven Ltd.
His former jobs include being a Medical Director at Merck & Co., Inc. from 2002 to 2010, Senior VP & Head-Global Medical Affairs at Alexion Pharmaceuticals, Inc. from 2015 to 2018, Head-Global Medical Affairs at GlaxoSmithKline LLC from 2010 to 2015, and Chief Medical Officer at Springworks Therapeutics, Inc. from 2018 to 2021.
He obtained his undergraduate degree from Copenhagen Business School and his graduate degree from the University of Copenhagen.
Aktive Positionen von Jens Renstrup
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOHAVEN LTD. | Chief Tech/Sci/R&D Officer | 01.01.2022 |
Ehemalige bekannte Positionen von Jens Renstrup
| Unternehmen | Position | Ende |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 27.07.2021 |
| ALEXION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.04.2018 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 01.06.2015 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01.01.2010 |
Ausbildung von Jens Renstrup
| Copenhagen Business School | Undergraduate Degree |
| University of Copenhagen | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
| BIOHAVEN LTD. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
